VIDEO: USPSTF official discusses new low-dose aspirin recommendations

Michael Walter | | Cardiovascular Business | Acute Coronary Syndromes

Barry, who is also a professor of medicine at Harvard Medical School, noted that the USPSTF updated its recommendations compared to the last guidelines were published in 2016. 

For high-risk patients between the ages of 40 to 59 with no prior history of CVD, the USPSTF concluded with “moderate certainty” that taking daily low-dose aspirin is associated with a “small net benefit.” This represents the group’s C grade, meaning that it ultimately comes down to each individual patient’s situation and a healthcare professional should be consulted before making any final decision.

The USPSTF does not recommended that patients 60 years old or older with no prior history of CVD take aspirin for this specific purpose, however, because it was linked to “no net benefit.” This represents the group’s D grade.

"There are two things to remember," Barry said. "One, these recommendation do not apply to people already taking aspirin. Those people should talk to their clinicians about the details of why they're on it and the risks and benefits. In addition, this does not apply to people who already have CVD or have had a stroke, heart attack or other evidence of atherosclerosis." 

Barry also emphasized that aspirin is "just one tool in the toolbox" for preventing CVD. Statin therapy, he added, is an effective intervention linked to reductions of 25 to 20% in cardiovascular endpoints. With aspirin, the reductions are closer to 10%. 

Read the full guideline recommendations at U.S. Preventive Services Task Force. Aspirin Use to Prevent Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement. JAMA. 2022;327(16):1577–1584. doi:10.1001/jama.2022.4983.

Related Acute Coronary Syndromes Content:

USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older

Unpaid student loan debt is bad for the heart

How the science behind COVID-19 vaccines could transform care for heart attack patients

Biden-Trump presidential election linked to a higher heart attack risk among white, male and older individuals

VIDEO: Cardiac CT now recommended as a front-line chest pain assessment tool

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed
New report raises questions about data that helped heart drug gain FDA approval
American College of Cardiology now supports early use of medication to treat obesity
Cannabis is bad for the heart—should the risk be taken more seriously?
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B
Meditation linked to ‘real, lasting benefits’ for high-risk heart patients

Around the web

Health Exec
Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.